SLX and CA19-9 levels in serum and bronchoalveolar lavage (BAL) fluid (U/ml)
| n | Serum SLX (positive rate) | Serum CA19-9 (positive rate) | BAL fluid SLX* | BAL fluid CA19-9** | |
|---|---|---|---|---|---|
| Data are expressed as mean (SD). | |||||
| UIP=usual interstitial pneumonia; NSIP=non-specific interstitial pneumonia; BOOP=bronchiolitis obliterans organising pneumonia; DPB=diffuse panbronchiolitis. | |||||
| *p=0.005 for the overall comparison of all six subject groups; **p=0.02 for the overall comparison of all six subject groups. | |||||
| Patients | 57 | ||||
| UIP | 19 | 35.5 (16.2); (33.3%) | 44.0 (78.7); (27.8%) | 103.7 (142.6) | 294.0 (792.0) |
| NSIP | 12 | 33.8 (6.8); (25.0%) | 50.4 (97.3); (25.0%) | 100.9 (161.4) | 159.8 (338.4) |
| BOOP | 8 | 37.8 (14.4); (50.0%) | 27.9 (31.7); (25.0%) | 107.3 (99.5) | 137.5 (202.5) |
| Sarcoidosis | 10 | 29.5 (7.3); (20.0%) | 18.8 (17.3); (20.0%) | 31.0 (11.7) | 60.3 (62.0) |
| DPB | 8 | 46.0 (23.4); (62.5%) | 66.1 (60.8); (62.5%) | 300.6 (304.4) | 1506.0 (2436.6) |
| Healthy volunteers | 9 | 29.3 (4.6); (0%) | 12.9 (8.5); (0%) | 21.2 (8.3) | 33.2 (63.0) |